Nasdaq · Technology
Definitive Healthcare Corp. (DH)
As-reported financials and recent SEC filings for Definitive Healthcare Corp., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$241.5M
Net income
$-138.9M
Net margin
-57.5%
Diluted EPS
$-1.30
ROE
-36.7%
P/E (TTM)
—
Market cap
$69.6M
Debt / equity
0.4×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $241.5M | $252.2M | $251.4M | $222.7M | $166.2M |
| Gross profit | $183.3M | $197.5M | $203.9M | $180.0M | — |
| Operating income | $-224.3M | $-710.8M | $-329.8M | $-44.0M | $-27.3M |
| Net income | $-138.9M | $-413.1M | $-202.4M | $-7.2M | $-17.8M |
| Diluted EPS | $-1.30 | $-3.54 | $-1.79 | $-0.07 | $-0.19 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-24
View on EDGAR →42026-06-09
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →8-K2026-06-05
View on EDGAR →42026-06-03
View on EDGAR →42026-06-03
View on EDGAR →Go deeper on DH
Search Definitive Healthcare Corp.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.